UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT


Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (date of earliest event reported): December 21, 2018





Encompass Health Corporation


(Exact name of Registrant as specified in its Charter)


Delaware


(State or Other Jurisdiction of Incorporation)


001-1031563-0860407(Commission File Number)(IRS Employer Identification No.)


9001 Liberty Parkway, Birmingham, Alabama 35242


(Address of Principal Executive Offices, Including Zip Code)


(205) 967-7116


(Registrant’s Telephone Number, Including Area Code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:





oWritten communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.     Emerging growth company o


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange   Act. o

















---










ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


After ongoing consultation with Mark J. Tarr, President and Chief Executive Officer of Encompass Health Corporation (“Encompass Health” or the “Company”), as part of a succession plan in development for some time, on December 21, 2018, Cheryl B. Levy, Chief Human Resources Officer of the Company, delivered written notice that she intends to retire effective March 31, 2019.





“Since joining the Company in 2007, Cheryl has had a profound impact on Encompass Health contributing to its culture and growth to what is now over 40,000 employees,” said Mr. Tarr.  “The staff and structure she put in place during her tenure will have a positive influence for years to come.”





The Company is considering both internal and external candidates as part of a national search for a new principal human resources officer. Ms. Levy will assist with the search and will continue to serve as Chief Human Resources Officer until March 31, 2019.




















---










SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.





ENCOMPASS HEALTH CORPORATIONBy:/S/   Patrick DarbyName:Patrick DarbyTitle:Executive Vice President, General Counseland Secretary





Dated: December 21, 2018